Market Closed -
Nasdaq Stockholm
09:03:21 2024-05-22 am EDT
|
5-day change
|
1st Jan Change
|
0.295
SEK
|
-1.67%
|
|
-1.67%
|
-32.80%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
125.7
|
46.7
|
25.68
|
17.21
|
Enterprise Value (EV)
1 |
113.3
|
41.27
|
25.36
|
17.45
|
P/E ratio
|
-6.13
x
|
-3.5
x
|
-1.7
x
|
-1.68
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
137
x
|
80.6
x
|
31
x
|
30.4
x
|
EV / Revenue
|
123
x
|
71.2
x
|
30.6
x
|
30.8
x
|
EV / EBITDA
|
-6.74
x
|
-3
x
|
-1.71
x
|
-1.64
x
|
EV / FCF
|
-7,064,255
x
|
-8,586,515
x
|
-4,202,227
x
|
-1,968,629
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
5.87
x
|
2.46
x
|
1.89
x
|
5.36
x
|
Nbr of stocks (in thousands)
|
25,661
|
25,661
|
34,245
|
51,367
|
Reference price
2 |
4.900
|
1.820
|
0.7500
|
0.3350
|
Announcement Date
|
5/6/20
|
4/23/21
|
4/26/22
|
6/11/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1.374
|
1.634
|
0.9207
|
0.5793
|
0.829
|
0.566
|
EBITDA
1 |
-4.909
|
-8.565
|
-16.82
|
-13.76
|
-14.84
|
-10.67
|
EBIT
1 |
-8.189
|
-12.55
|
-17.23
|
-14.2
|
-15.17
|
-10.97
|
Operating Margin
|
-596.15%
|
-768.3%
|
-1,871.77%
|
-2,451.17%
|
-1,829.92%
|
-1,938.69%
|
Earnings before Tax (EBT)
1 |
-8.223
|
-12.85
|
-19.37
|
-13.4
|
-15.17
|
-10.41
|
Net income
1 |
-8.223
|
-12.85
|
-19.37
|
-13.4
|
-15.17
|
-10.41
|
Net margin
|
-598.6%
|
-786.13%
|
-2,103.45%
|
-2,313.62%
|
-1,830.16%
|
-1,839.05%
|
EPS
|
-
|
-0.6000
|
-0.8000
|
-0.5200
|
-0.4400
|
-0.2000
|
Free Cash Flow
|
-
|
-5.961
|
-16.04
|
-4.807
|
-6.036
|
-8.862
|
FCF margin
|
-
|
-364.83%
|
-1,742.06%
|
-829.75%
|
-728.05%
|
-1,565.81%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/23/18
|
3/8/19
|
5/6/20
|
4/23/21
|
4/26/22
|
6/11/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
0.24
|
Net Cash position
1 |
0.53
|
3.51
|
12.4
|
5.43
|
0.32
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.0224
x
|
Free Cash Flow
|
-
|
-5.96
|
-16
|
-4.81
|
-6.04
|
-8.86
|
ROE (net income / shareholders' equity)
|
-211%
|
-159%
|
-129%
|
-66.4%
|
-93%
|
-124%
|
ROA (Net income/ Total Assets)
|
-45.9%
|
-54.4%
|
-55.2%
|
-38.2%
|
-45.3%
|
-55.1%
|
Assets
1 |
17.92
|
23.62
|
35.06
|
35.04
|
33.48
|
18.91
|
Book Value Per Share
|
-
|
0.3400
|
0.8300
|
0.7400
|
0.4000
|
0.0600
|
Cash Flow per Share
|
-
|
0.1400
|
0.4800
|
0.2100
|
0.0100
|
0.0200
|
Capex
|
-
|
-
|
0.21
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
22.53%
|
-
|
-
|
-
|
Announcement Date
|
5/23/18
|
3/8/19
|
5/6/20
|
4/23/21
|
4/26/22
|
6/11/23
|
|
1st Jan change
|
Capi.
|
---|
| -32.80% | 2.68M | | +17.82% | 66.74B | | +2.85% | 49.42B | | +19.89% | 42.17B | | +21.48% | 26.37B | | +9.99% | 19.17B | | -1.39% | 16.73B | | +5.98% | 15.99B | | -27.02% | 14.85B | | -12.46% | 14.86B |
Other Specialty Chemicals
|